Company Profile

 China Meheco Co., Ltd. is a state-holding company listed at Shanghai Stock Exchange, (Ticker Symbol: China Meheco; Stock Code: 600056) and its controlling shareholder is China General Technology (Group) Holding Co., Ltd., an important backbone state-owned enterprise directly administered by the central government. Upholding the tenet of "Cherishing Life and Seeking Excellence", China Meheco is dedicated to the promotion of human health and the development of pharmaceutical industry, endeavoring to become a flagship pharmaceutical enterprise in China.

China Meheco has established a comprehensive business framework that is guided by international trade, supported by pharmaceutical manufacture and coordinated by pharmaceutical commerce. Its business scope fully covers the whole industry chain, from R & D, cultivation & processing, manufacturing, distribution, logistics to international trading, academic promotion and technical service etc.

In the future, the company will focus on building sales network in both domestic and international markets for core products of modern Traditional Chinese Medicine, distinctive chemical preparation and bio-pharmaceutical preparations, to create an industrial chain which fully integrates R & D, production, sales and services. China Meheco strives to become a large-scale integrative pharmaceutical group with high position among domestic peers, and with worldwide renown for its great brand influence and high competitiveness.